Open AccessConsensus statement on immune modulation in multiple sclerosis and related disorders during the covid-19 pandemic: Expert group on behalf of the indian academy of neurology
Author(s) -
Rohit Bhatia,
M V Padma Srivastava,
Dheeraj Khurana,
Lekha Pandit,
Thomas Mathew,
Salil Gupta,
M Netravathi,
Sruthi S Nair,
Gagandeep Singh,
Bhim Singhal
Publication year - 2020
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/0972-2327.282442
Subject(s) - pandemic , medicine , multiple sclerosis , covid-19 , neurology , coronavirus , statement (logic) , expert opinion , betacoronavirus , immune modulation , demyelinating disorder , family medicine , immune system , intensive care medicine , immunology , psychiatry , virology , pathology , political science , disease , outbreak , infectious disease (medical specialty) , law
Knowledge related to SARS-CoV-2 or 2019 novel coronavirus (2019-nCoV) is still emerging and rapidly evolving. We know little about the effects of this novel coronavirus on various body systems and its behaviour among patients with underlying neurological conditions, especially those on immunomodulatory medications. The aim of the present consensus expert opinion document is to appraise the potential concerns when managing our patients with underlying CNS autoimmune demyelinating disorders during the current COVID-19 pandemic.